UNSPSC 51283002: Clindamycin

This classification denotes a lincosamide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3U02EL437C. European Medicines Agency schedules Clindamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06665MIG. Clindamycin generally arises in the molecular formula C18H33CLN2O5S.

UNSPSC 51283002 Clindamycin is a Commodity code covering pharmaceutical products. State and local governments procure clindamycin and related antibiotics through warehouse and institutional purchasing vehicles, typically as part of broader pharmaceutical supply contracts managed by public health departments, county health systems, and emergency response agencies. The work involves supplying finished pharmaceutical products in standardized unit packages to public health facilities, emergency medical services, and community health centers on regular delivery schedules, often through piggyback contracts or cooperative purchasing consortia that leverage existing master agreements to achieve volume pricing and expedited procurement cycles.

Activity under this code spans state health departments, county public health agencies, and community health systems. The Illinois Department of Public Health has recently awarded pharmaceutical warehouse contracts through the MMCAP Infuse consortium, and Seminole County, Florida has solicited naloxone and drug deactivation systems on an annual basis through competitive bidding. Recent opportunities show activity primarily in Florida and Illinois, with procurement centered on emergency medical and public health supply chains. The Illinois Department of Public Health awarded a contract to Chartwell Rx LLC on August 28, 2026 under IFB 26482DPHPREPDB53392 for pharmaceutical products including antibiotics through a piggyback arrangement, with a total contract value of $2,999,999.11 over three years. Seminole County, Florida issued IFB 60459723LAS with a response deadline of July 26, 2023 for naloxone and drug deactivation systems on a competitive basis, requiring quarterly deliveries to the Seminole County Community Health Building in Sanford.